Saudi Arabia to produce AstraZeneca, Pfizer COVID-19 vaccines locally
Memorandums of understanding will be signed in the field of pharmaceutical manufacturing
Vials labelled with broken sticker "AstraZeneca COVID-19 Coronavirus Vaccine" and a broken syringe are seen in front of a displayed AstraZeneca logo in this illustration taken March 15, 2021.
By Staff Writer, Arab News
RIYADH: Saudi Arabia is expected to sign agreements with international pharmaceutical companies, among them AstraZeneca and Pfizer to manufacture COVID-19 vaccines locally, as part of the activities of the Riyadh International Summit for Medical Technology, Asharq reported.
The summit will start today in Riyadh, in the presence of the ministers of finance, investment, health and industry.
Memorandums of understanding will be signed in the field of pharmaceutical manufacturing and medical technology between a number of international companies specialized in these fields and between the Ministry of Investment and Health Affairs at the Ministry of National Guard, sources told Asharq.
The summit is scheduled to discuss scientific topics, such as opportunities and challenges related to medical biotechnology in Saudi Arabia, the investment strategy towards medical biotechnology, and the role of biotechnology in developing drugs, vaccines, and cellular and genetic therapies.
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
Get Zawya's daily newsletter for insightful and exclusive Middle East perspectives on business and finance. SUBSCRIBE NOW